Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.

JK Björk; I Ahonen; T Mirtti; A Erickson; A Rannikko; A Bützow; S Nordling; J Lundin; M Lundin; Lea Sistonen; M Nees; Malin Åkerfelt

doi:10.18632/oncotarget.25756

Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.

JK Björk, I Ahonen, T Mirtti, A Erickson, A Rannikko, A Bützow, S Nordling, J Lundin, M Lundin, Lea Sistonen, M Nees, Malin Åkerfelt

Research output: Contribution to journal › Article › Scientific › peer-review

16 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	–
Journal	Oncotarget
Volume	9
DOIs	https://doi.org/10.18632/oncotarget.25756
Publication status	Published - 2018
MoE publication type	A1 Journal article-refereed

Access to Document

10.18632/oncotarget.25756

Björk et al. 2018.pdfFinal published version, 6.71 MBLicence: Publisher rights policy

http://urn.fi/URN:NBN:fi-fe2020100883022

Cite this

@article{d2db764ed9244ee8b1f386ee3c3f521a,

title = "Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.",

author = "JK Bj{\"o}rk and I Ahonen and T Mirtti and A Erickson and A Rannikko and A B{\"u}tzow and S Nordling and J Lundin and M Lundin and Lea Sistonen and M Nees and Malin {\AA}kerfelt",

year = "2018",

doi = "10.18632/oncotarget.25756",

language = "Odefinierat/ok{\"a}nt",

volume = "9",

pages = "–",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

}

TY - JOUR

T1 - Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.

AU - Björk, JK

AU - Ahonen, I

AU - Mirtti, T

AU - Erickson, A

AU - Rannikko, A

AU - Bützow, A

AU - Nordling, S

AU - Lundin, J

AU - Lundin, M

AU - Sistonen, Lea

AU - Nees, M

AU - Åkerfelt, Malin

PY - 2018

Y1 - 2018

U2 - 10.18632/oncotarget.25756

DO - 10.18632/oncotarget.25756

M3 - Artikel

SN - 1949-2553

VL - 9

SP - –

JO - Oncotarget

JF - Oncotarget

ER -